Matrixyl Palmitoyl Pentapeptide-4 ECM Research
Dermatology Research

Palmitoyl Pentapeptide-4 (Matrixyl): Extracellular Matrix Reconstruction

13 min read

Key Research Takeaways

  • Matrixyl is a lipopeptide consisting of a pentapeptide (KTTKS) conjugated to palmitic acid
  • The KTTKS sequence is derived from procollagen I, acting as a matrikine signaling molecule
  • Research demonstrates stimulation of collagen, fibronectin, and glycosaminoglycan synthesis
  • The palmitoyl modification enhances skin penetration and cellular uptake

The extracellular matrix (ECM) of skin provides structural support and undergoes constant remodeling. Fragments of ECM proteins—termed matrikines—can act as signaling molecules, instructing cells to synthesize new matrix components. Palmitoyl Pentapeptide-4, commercially known as Matrixyl, exemplifies this concept. Based on a collagen-derived sequence, this lipopeptide has become one of the most extensively studied signal peptides in dermatological research. This analysis examines its matrikine mechanism, structural design, and research applications.

The Matrikine Concept

ECM-Derived Signaling

The extracellular matrix is not merely a structural scaffold—it communicates with cells through bioactive fragments:

  • Matrikines: ECM fragments with signaling activity
  • Origin: Produced during normal matrix turnover or injury
  • Receptors: Often bind to integrins or other cell-surface receptors
  • Function: Feedback signaling for tissue repair and remodeling

This concept emerged from observations that small peptide fragments from collagen and other ECM proteins could stimulate fibroblasts to produce new matrix—a natural wound healing signal repurposed for research.

The KTTKS Sequence

The pentapeptide KTTKS derives from the C-terminal propeptide of type I procollagen:

Lysine – Threonine – Threonine – Lysine – Serine (Lys-Thr-Thr-Lys-Ser)

This sequence:

  • Occurs naturally during procollagen processing
  • Released when procollagen is cleaved to form mature collagen
  • Acts as a feedback signal indicating matrix synthesis is needed
  • Stimulates fibroblasts to increase ECM production

Palmitoyl Pentapeptide-4: Structure

Lipopeptide Design

Matrixyl is not simply KTTKS—it’s a strategically modified lipopeptide:

Palmitic acid – Lys – Thr – Thr – Lys – Ser

The palmitoyl (C16 fatty acid) modification serves multiple purposes:

  • Lipophilicity: Increases membrane interaction and penetration
  • Stability: Protects against enzymatic degradation
  • Skin permeation: Enhanced passage through stratum corneum
  • Cellular uptake: Improved internalization into target cells

Physicochemical Properties

Property Value
INCI Name Palmitoyl Pentapeptide-4
Trade Name Matrixyl
Molecular Weight ~803 Da
Peptide Sequence KTTKS
Lipid Modification Palmitic acid (C16)
Solubility Water/glycerin soluble

Mechanism of Action

Matrikine Signaling

Palmitoyl Pentapeptide-4’s mechanism centers on mimicking natural matrikine signaling:

  1. Penetration: Lipopeptide crosses skin barrier
  2. Recognition: Recognized by fibroblast receptors (likely integrins)
  3. Signal transduction: Activates matrix synthesis pathways
  4. Gene expression: Upregulates ECM protein genes
  5. Matrix production: Increased collagen, fibronectin, elastin synthesis
“The elegance of matrikine peptides like Matrixyl lies in their exploitation of natural feedback mechanisms. Rather than introducing an exogenous signal, they amplify an endogenous repair response—the signal fibroblasts already ‘understand’ from wound healing.” — Matrix Biology Research Review, 2021

Cellular Targets

Primary cellular effects include:

  • Fibroblasts: Main target for collagen/elastin production
  • Keratinocytes: Effects on epidermal function
  • Potential receptor: α5β1 integrin implicated

ECM Components Affected

Research has demonstrated effects on multiple ECM proteins:

  • Collagen I: Primary structural protein—significantly upregulated
  • Collagen III: Elastic collagen type—increased
  • Collagen IV: Basement membrane collagen
  • Fibronectin: Cell-matrix adhesion protein
  • Hyaluronic acid: Glycosaminoglycan for hydration
  • Elastin: Elastic fiber protein

Research Evidence

In Vitro Studies

Cell culture experiments have demonstrated:

  • Collagen synthesis: Dose-dependent increase in procollagen production
  • Gene expression: Upregulation of COL1A1, COL3A1 genes
  • Fibronectin: Enhanced production in fibroblast cultures
  • GAG synthesis: Increased glycosaminoglycan production

Ex Vivo Studies

Skin explant and organ culture models show:

  • Enhanced matrix deposition in dermal tissue
  • Improved dermal-epidermal junction integrity
  • Effects comparable to or exceeding retinoids in some endpoints

Clinical Research

Published clinical studies have reported:

  • Wrinkle reduction: Measurable decreases in wrinkle depth
  • Skin roughness: Improved smoothness parameters
  • Skin thickness: Increased dermal density on ultrasound
  • Timeline: Effects typically observed after 2-4 months

Matrixyl Family Evolution

Original Matrixyl

The original Palmitoyl Pentapeptide-4 (Matrixyl) established the proof-of-concept for collagen-derived signal peptides.

Matrixyl 3000

A combination product containing:

  • Palmitoyl Tripeptide-1: GHK sequence (palmitated)
  • Palmitoyl Tetrapeptide-7: Anti-inflammatory peptide
  • Rationale: Synergistic matrix stimulation and inflammation control

Matrixyl Synthe’6

Next-generation formulation including:

  • Palmitoyl Tripeptide-38: Stimulates 6 major matrix components
  • Broader ECM effects: Collagen I, III, IV, fibronectin, hyaluronic acid, laminin-5

Comparison with Related Peptides

Peptide Sequence Origin Primary Effect
Pal-KTTKS (Matrixyl) Procollagen I Collagen/ECM synthesis
GHK-Cu Plasma protein Broad ECM effects
Pal-GHK GHK + palmitoyl Enhanced penetration
Argireline SNAP-25 Neuromuscular modulation

Research Applications

Matrix Biology Studies

Matrixyl serves as a tool for investigating:

  • Matrikine signaling mechanisms
  • Fibroblast response to ECM fragments
  • Integrin-mediated signal transduction
  • Coordination of ECM component synthesis

Skin Aging Research

Applications in aging skin models:

  • Comparison with retinoids and other interventions
  • Effects on aged fibroblast phenotype
  • Reversal of matrix degradation
  • Combination approaches with antioxidants

Wound Healing Models

Potential applications include:

  • Acceleration of matrix deposition in wound models
  • Effects on granulation tissue formation
  • Comparison with growth factors
  • Scar formation modulation

Delivery System Development

The lipopeptide structure enables delivery research:

  • Penetration studies: Role of palmitoyl in skin permeation
  • Formulation optimization: Vehicle effects on delivery
  • Alternative lipids: Other fatty acid conjugations

Formulation Considerations

Stability

Key stability factors:

  • pH: Stable across physiological pH range
  • Temperature: Sensitive to elevated temperatures
  • Oxidation: Palmitate subject to oxidation—antioxidants recommended
  • Light: Generally photostable

Concentration Ranges

Research formulations typically use:

  • In vitro: 1-10 ppm active peptide
  • Topical research: 2-8 ppm common ranges
  • Commercial reference: Often supplied as solutions/premixes

Compatibility

Formulation compatibility:

  • pH range: 4.0-7.0 optimal
  • Compatible: Most cosmetic ingredients
  • Synergistic: Vitamin C, retinoids, other peptides
  • Avoid: Strong oxidizers, extreme pH

Quality Considerations

Identity Verification

  • Sequence confirmation: Mass spectrometry for peptide identity
  • Fatty acid verification: Confirm palmitoyl attachment
  • Purity: HPLC analysis for impurity profile

Research-Grade Specifications

  • Purity: ≥95% by HPLC
  • Identity: MS confirmation of molecular weight
  • Form: Lyophilized powder or solution
  • Storage: -20°C recommended for long-term stability

Future Directions

Active research areas include:

  • Receptor identification: Definitive characterization of cellular targets
  • Signaling pathway mapping: Complete mechanism elucidation
  • New matrikine sequences: Discovery of additional bioactive fragments
  • Combination optimization: Synergistic formulations with other actives
  • Delivery enhancement: Nanoparticles, penetration enhancers

Conclusion

Palmitoyl Pentapeptide-4 (Matrixyl) exemplifies the matrikine concept—using naturally derived signaling sequences to stimulate tissue repair pathways. The KTTKS sequence from procollagen I, enhanced with palmitic acid for improved delivery, activates fibroblasts to produce multiple ECM components.

As a research tool, Matrixyl enables investigation of matrix biology, matrikine signaling, and the coordination of ECM synthesis. Its lipopeptide structure also serves as a model for understanding how fatty acid modification affects peptide delivery and bioactivity.

Regenpep provides research-grade Palmitoyl Pentapeptide-4 with comprehensive quality documentation including HPLC purity analysis and mass spectrometry verification. Our commitment to quality supports rigorous investigation of matrix-stimulating peptides.

About the Regenpep Research Team

The Regenpep Research Team consists of biochemists, molecular biologists, and dermatology research specialists with extensive experience in peptide biology and matrix science. Our team reviews current scientific literature and synthesizes complex findings into accessible, accurate content for the research community.

Disclaimer: This article is intended for educational and informational purposes only. All Regenpep products are sold exclusively for laboratory research use. Not for human consumption.

References & Further Reading

  1. 1. Katayama K, et al. “A pentapeptide from type I procollagen promotes extracellular matrix production.” Journal of Biological Chemistry. 1993;268(14):9941-9944. → PubMed
  2. 2. Robinson LR, et al. “Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin.” International Journal of Cosmetic Science. 2005;27(3):155-160. → PubMed
  3. 3. Maquart FX, et al. “Matrikines and matricryptins: from protein fragments to active peptides.” Drug Discovery Today. 2004;9(17):776-785. → PubMed
  4. 4. Lintner K, Peschard O. “Biologically active peptides: from a laboratory bench curiosity to a functional skin care product.” International Journal of Cosmetic Science. 2000;22(3):207-218. → PubMed
  5. 5. Schagen SK. “Topical peptide treatments with effective anti-aging results.” Cosmetics. 2017;4(2):16.

Access Research-Grade Matrix Peptides

Regenpep provides high-purity Palmitoyl Pentapeptide-4 and related peptides with full analytical verification. Support your dermatological research with verified reference materials.

Regenpep - Footer

Your Cart

Your cart is empty

Top Picks

Loading products...